The 4th Risk Evaluation and Mitigation Strategies Summit brings together executives from the industry to prepare for the changing landscape of REMS. Your REMS program is a marathon race and you must stay ahead of the curve to ensure your drugs are staying compliant while ensuring accessibility and success in market.
By attending this year’s event, you will benefit from one of the only conferences focused specifically on REMS and the strategies to design a rigorous program that meets FDA regulations. Hear from experienced professionals the best practices to complete successful REMS assessment and streamline your clinical, safety, regulatory, and marketing sectors to ensure financial viability in the market.
Top Five Reasons to Attend
“Very relevant and at an appropriate level…”
Senior Manager, Lundbeck
“Very interesting global perspective.”
Director, ParagonRx
“Really interesting take and very thorough…good discussion”
Director, Amgen
“Excellent, timely, and relevant!”
Pharmacovigilance Specialist, Teva USA
Justify Your Trip!
If you have to first convince your boss it’s worth your time and the company’s money to attend this event, you’re not alone. Past conference attendees have helped us create the following justification document that will let you make your case on why this is a must-attend conference for you. Feel free to download and customize the letter below as you see fit, adding immediate problems you’ll be able to solve and long-term initiatives you’ll be able to implement. Chances are good you’ll be able to do those things and more after the conclusion of our 2012 event!
This conference is designed for representatives from pharmaceutical, biotech, medical device and clinical research companies with responsibilities in the following areas:
Directors, Heads, Managers, Vice Presidents, of:
This conference is also of interest to: